Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients

NCT00398879 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT00398879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00398879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients
Lead sponsor
AEterna Zentaris
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2005
Completion date
October 31, 2011
Enrollment
381 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer